2.3250
-0.0450
(-1.90%)
As of 11:53:25 AM EDT. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.03 | -0.03 | -0.15 | -0.17 |
| Low Estimate | -0.03 | -0.03 | -0.15 | -0.17 |
| High Estimate | -0.03 | -0.03 | -0.15 | -0.17 |
| Year Ago EPS | -- | -- | -0.29 | -0.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 156k | 156k | 571k | 520k |
| Low Estimate | 156k | 156k | 571k | 520k |
| High Estimate | 156k | 156k | 571k | 520k |
| Year Ago Sales | -- | -- | -- | 571k |
| Sales Growth (year/est) | -- | -- | -- | -8.93% |
Earnings History
| Currency in USD | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|
| EPS Est. | -0.06 | -0.05 | -0.05 |
| EPS Actual | -- | -- | -- |
| Difference | -- | -- | -- |
| Surprise % | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.03 | -0.15 | -0.17 |
| 7 Days Ago | -0.04 | -0.04 | -0.17 | -0.17 |
| 30 Days Ago | -0.04 | -0.04 | -0.17 | -0.17 |
| 60 Days Ago | -0.04 | -0.04 | -0.17 | -0.17 |
| 90 Days Ago | -0.04 | -0.04 | -0.17 | -0.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GDTC | -- | -- | 47.58% | -13.33% |
| S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 10/10/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 6/11/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 12/4/2023 |
| Initiated | Benchmark: Speculative Buy | 7/21/2023 |
Related Tickers
CSBR Champions Oncology, Inc.
7.98
+6.43%
NBY NovaBay Pharmaceuticals, Inc.
0.4901
-5.17%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0077
-21.25%
COEP Coeptis Therapeutics Holdings, Inc.
9.25
-4.37%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.7700
+0.57%
ONPH Oncology Pharma Inc.
0.0001
0.00%
KTTA Pasithea Therapeutics Corp.
1.2200
-3.94%
CHRO Channel Therapeutics Corporation
1.3100
-3.94%
INTS Intensity Therapeutics, Inc.
1.8700
0.00%
IMRN Immuron Limited
1.7650
+0.28%